Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

By Catalona W.J.   Partin A.W.   Finlay J.A.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen

By Lechevallier E.   Eghazarian C.   Ortega J.-C.   Roux F.   Coulange C.  

Urology, Vol. 54, Iss. 5, 1999-11 ,pp. : 857-861

Elsevier

Access to resources Recommend Favorite

Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

By Chen Y.-T.   Luderer A.A.   Thiel R.P.   Carlson G.   Cuny C.L.   Soriano T.F.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 518-524

Elsevier

Access to resources Recommend Favorite

Estimation of Prostate Cancer Risk on the Basis of Total and Free Prostate-Specific Antigen, Prostate Volume and Digital Rectal Examination

By Finne P.   Auvinen A.   Aro J.   Juusela H.   Maattanen L.   Rannikko S.   Hakama M.   Tammela T.L.J.   Stenman U.-H.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 619-627

Elsevier

Access to resources Recommend Favorite

Percent free prostate-specific antigen after radiotherapy for prostate cancer - 8 to 10 ng/mL total PSA

By Crook J.M.   Bunting P.S.  

Urology, Vol. 52, Iss. 1, 1998-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite